Delivery Order SPE2DB20D1100-SPE2DB24FD9D4
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,667.25 firm fixed-price contract is for the provision of 40 mg vials of the drug mitomycin, a chemotherapy medication. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,818.90, is for the delivery of Mitomycin 5 mg vials, a specialty cancer medication. The contract is a firm fixed-price, delivery order type with a completion date of May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,201.40 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 20 mg vials of the cancer drug mitomycin. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mitomycin 40 mg vials, a specialty medication, with a ceiling value of $5,676.96 and a period of performance through January 9, 2025. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Mitomycin 5 mg vials. The contract has a firm fixed price of $1,636.92 and a completion date of January 19, 2022. This award is not designated as a set-aside contract. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of Cencora, Inc., a for-profit pharmaceutical distribution company. This contract is part of a larger...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEBU6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567480094 - Mitomycin 5 mg vials, with a ceiling value of $2,751.36 and a completion date of March 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Mitomycin 5 mg vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,818.90 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
The Defense Logistics Agency awarded a $5,326 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312732 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 27, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract...
The Defense Logistics Agency awarded a $1,843 delivery order contract to Amerisourcebergen Drug Corporation for 5 mg vials of the chemotherapy drug mitomycin. As a prime contractor for DLA's pharmaceutical supply program, Amerisourcebergen will deliver the vials to a customer located in Conshohocken, Pennsylvania. The firm fixed price order is for a one-day period of performance from July 25 to July 26, 2023, to fulfill a customer's near-term chemotherapy needs. No subcontractors or set aside...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $565 to Amerisourcebergen Drug Corporation to supply 4561985811 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S....